Document Detail

Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy.
MedLine Citation:
PMID:  8858459     Owner:  NLM     Status:  MEDLINE    
The aim of the present study was to determine the in-vitro susceptibility of Toxoplasma gondii to dihydrofolate reductase inhibitors and sulphonamides alone, and in combination. It was found that pyrimethamine had the most potent anti-Toxoplasma activity, while sulphadiazine, sulphamethoxazole and sulphametrole were approximately equally effective, but only at a high concentration. The 50% inhibitory concentration of sulphamethoxazole was determined using different fixed concentrations of pyrimethamine or trimethoprim. It was found that a ten-fold increment of the concentration of pyrimethamine, reduced the IC50 of sulphamethoxazole 1000 times. The influence of trimethoprim on the IC50 of sulphamethoxazole was less concentration dependent. Addition of dihydrofolate or tetrahydrofolate did not influence the IC50 of pyrimethamine. In conclusion, the present dose recommendations for sulphonamides, when combined with pyrimethamine, may be unnecessarily high. There may be a justification for dose reduction of sulphonamides in order to prevent side effects.
A J van der Ven; E M Schoondermark-van de Ven; W Camps; W J Melchers; P P Koopmans; J W van der Meer; J M Galama
Related Documents :
3889629 - Fate of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (iq) in sprague-dawley...
8584449 - Iron repletion attenuates the protective effects of iron deficiency in dmba-induced mam...
16931879 - Comparative effects of the addition of mutton or beef to a bean seed ragout on iron sta...
2276219 - Hepatic iron and iron absorption in hemochromatosis.
22542959 - Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid...
9446839 - Increases in the concentrations of available iron in response to dietary iron supplemen...
6158489 - Diet and adjuvant-induced arthritis in the rat.
21094359 - Effect of central obesity, low high-density lipoprotein cholesterol and c-reactive prot...
2291809 - Effect of germinated and heated soybean meals on plasma cholesterol and triglycerides i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  38     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1997-02-10     Completed Date:  1997-02-10     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  75-80     Citation Subset:  IM    
Department of General Internal Medicine, University Hospital Nijmegen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Infective Agents / therapeutic use*
Enzyme Inhibitors / therapeutic use*
Folic Acid Antagonists / therapeutic use*
Microbial Sensitivity Tests
Pyrimethamine / therapeutic use
Sulfonamides / therapeutic use
Toxoplasma / drug effects*
Trimethoprim / therapeutic use
Reg. No./Substance:
0/Anti-Infective Agents; 0/Enzyme Inhibitors; 0/Folic Acid Antagonists; 0/Sulfonamides; 58-14-0/Pyrimethamine; 738-70-5/Trimethoprim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans...
Next Document:  Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro.